Table A.1 Outline of the appraisal questions for aquatic organisms
Section | Acronym | Question |
---|---|---|
External validity | Q1_EV | How confident are we that the assessment endpoint can be used to inform the risk assessment of aquatic organisms? |
Q2_EV | Are the test organisms exposed to either flupyradifurone or acetamiprid in isolation (without any other active substances)? | |
Q3_EV | Are the tested organisms relevant for Europe? | |
Q4_EV | Is the duration of the exposure and observation in line with the standard testing? | |
Internal validity | Q1_IV | Is the origin of the tested organism trustable? |
Q2_IV | Is the age and sex of the tested organisms known and appropriate? | |
Q3_IV | Were the test organisms properly acclimatised to the study setup before the exposure started? | |
Q4_IV | Are the test organisms healthy and stress‐free at the start of the experiment? | |
Q5_IV | Is the methodology used (including the experimental setup) for measuring the assessment endpoint reliable? | |
Q6_IV | Is the negative (blank) control performing adequately? | |
Q7_IV | If a solvent is used, is the effect of the solvent appropriately accounted for? | |
Q8_IV |
Are the test conditions appropriate? This includes relevant OECD validity criteria concerning optimal tests conditions for the tested species (e.g. oxygen saturation). |
|
Q9_IV | Is the test item clearly identified and characterised? | |
Q10_IV | Is exposure characterised by analytical measurements and is it maintained during the test duration? | |
Q11_IV | Was a clear dose response observed in the study? | |
Q12_IV | Is the derivation of the measured endpoint(s) performed with sound statistical methods? | |
Precision | Q1_PR | Are the sample size and replication appropriate? |
Q2_PR | Is the number of tested concentrations/doses appropriate? | |
Q3_PR | Is doses selection (including the space between them) appropriate? |